nach oben

European Journal of Pediatrics

Erschienen in:

01.01.2013 | Review

The controversy regarding the need for hormonal treatment in boys with unilateral cryptorchidism goes on: a review of the literature

verfasst von: Barbara Ludwikowski, Ricardo González

Erschienen in: European Journal of Pediatrics | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Hormonal treatment for unilateral undescended testes continues to be recommended in some countries. We reviewed the literature in favor and against this recommendation. Since the paternity rate of men with a history of unilateral undescended testes only treated with surgery is normal, the effectiveness of hormonal treatment to produce testicular descent is low, the cost is considerable, and there are potential adverse effects, hormonal treatment for boys with unilateral undescended testes should no longer be recommended.

Atkinson PM (1975) A follow-up study of surgically treated cryptorchid patients. J Pediatr Surg 10:115–119PubMedCrossRef

Barthold JS (2008) Undescended testis: current theories of etiology. Curr Opin Urol 18(4):395–400PubMedCrossRef

Barthold JS, Manson J, Regan V, Si X, Hassink SG, Coughlin MT, Lee PA (2004) Reproductive hormone levels in infants with cryptorchidism during postnatal activation of the pituitary-testicular axis. J Urol 172:1736–1741PubMedCrossRef

Biers SM, Malone PS (2010) A critical appraisal of the evidence for improved fertility indices in undescended testes after gonadotrophin-releasing hormone therapy and orchidopexy. J Pediatr Urol 6:239–246PubMedCrossRef

Borgward TG (2004) Bernhard Schapiro (1888-1966): Talmudic scholar-andrologist-pioneer of hormonal Treatment for cryptorchidism. Wurzbg Medizinhist Mitt 23:393–411

Callaghan P (2000) Undescended testis. Pediatr Rev 21:395PubMed

CendronM KMA, Huff DS, Koop CE, Snyder HM 3rd, Duckett JW (1989) Cryptorchidism, orchiopexy and infertility: a critical long-term retrospective analysis. J Urol 142:559–562

Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, Haugen TB, Kruger T, Wang C, Mbizvo MT, Vogelsong KM (2010) World Health Organization reference values for human semen characteristics. Hum Reprod Update 16:231–245PubMedCrossRef

Cortes D, Thorup J, Lindenberg S, Visfeldt J (2003) Infertility despite surgery for cryptorchidism in childhood can be classified by patients with normal or elevated follicle-stimulating hormone and identified at orchidopexy. BJU Int 91:670–674PubMedCrossRef

10.

Cortes D, Thorup J, Visfeldt J (2000) Hormonal treatment may harm the germ cells in 1 to 3-year-old boys with cryptorchidism. J Urol 163:1290–1292PubMedCrossRef

11.

Cortes D, Thorup JM, Visfeldt J (2001) Cryptorchidism: aspects of fertility and neoplasms. A study including data of 1335 consecutive boys who underwent testicular biopsy simultaneously with surgery for cryptorchidism. Horm Res 55:21–27PubMedCrossRef

12.

De Muinck Keizer-Schrama SM, Hazebroek FW, Drop SL, Degenhart HJ, Molenaar JC, Visser HK (1988) Hormonal evaluation of boys born with undescended testes during their first year of life. J Clin Endocrinol Metab 66:159–164PubMedCrossRef

13.

Demirbilek S, Atayurt HF, Celik N, Aydin G (1997) Does treatment with human chorionic gonadotropin induce reversible changes in undescended testes in boys? Pediatr Surg Int 12:591–594PubMedCrossRef

14.

Dunkel L, Taskinen S, Hovatta O, Tilly JL, Wikström S (1997) Germ cell apoptosis after treatment of cryptorchidism with human chorionic gonadotropin is associated with impaired reproductive function in the adult. J Clin Invest 100:2341–2346PubMedCrossRef

15.

Fallon B, Kennedy TJ (1985) Long-term follow-up of fertility in cryptorchid patients. Urology 25:502–504PubMedCrossRef

16.

Fanconi S, Reinberg O, Gapany G, Meyrat BJ, Frey F, Vaudaux B, Di Bernardo S, Boulos T, Sekarski S, Spehrs-Ciaffi V, Jeannet PY (2008) Pediatrics. Rev Med Suisse 4:61–66PubMed

17.

Forest MG, Sizonenko PC, Cathiard AM, Bertrand J (1974) Hypophyso-gonadal function in humans during the first year of life. 1. Evidence for testicular activity in early infancy. J Clin Invest 53:819–828PubMedCrossRef

18.

Hadziselimovic F, Emmons LR, Buser MW (2004) A diminished postnatal surge of Ad spermatogonia in cryptorchid infants is additional evidence for hypogonadotropic hypogonadism. Swiss Med Wkly 134:381–384PubMed

19.

Hadziselimovic F, Herzog B (2001) Importance of early postnatal germ cell maturation for fertility of cryptorchid males. Horm Res 55:6–10PubMedCrossRef

20.

Hadziselimovic F, Hocht B, Herzog B, Buser MW (2007) Infertility in cryptorchidism is linked to the stage of germ cell development at orchidopexy. Horm Res 68:46–52PubMedCrossRef

21.

Jallouli M, Rebai T, Abid N, Bendhaou M, Kassis M, Mhiri R (2009) Neoadjuvant gonadotropin-releasing hormone therapy before surgery and effect on fertility index in unilateral undescended testes: a prospective randomized trial. Urology 73:1251–1254PubMedCrossRef

22.

Job JC, Toublanc JE, Chaussain JL, Gendrel D, Roger M, Canlorbe P (1987) The pituitary-gonadal axis in cryptorchid infants and children. Eur J Pediatr 146:S2–S5PubMedCrossRef

23.

Kollin C, Karpe B, Hesser U, Granholm T, Ritzén EM (2007) Surgical treatment of unilaterally undescended testes: testicular growth after randomization to orchiopexy at age 9 months or 3 years. J Urol 178:1589–1593PubMedCrossRef

24.

Lala R, Matarazzo P, Chiabotto P, de Sanctis C, Canavese F, Hadziselimovic F (1993) Combined therapy with Lhrh and Hcg in cryptorchid infants. Eur J Pediatr 152:S31–S33PubMedCrossRef

25.

Lee PA, O'Leary LA, Songer NJ, Coughlin MT, Bellinger MF, LaPorte RE (1996) Paternity after unilateral cryptorchidism: a controlled study. Pediatrics 98:676–679PubMed

26.

Lee PA, Coughlin MT (2002) The single testis: paternity after presentation as unilateral cryptorchidism. J Urol 168:1680–1682PubMedCrossRef

27.

Lee PA, Coughlin MT, Bellinger MF (2000) Paternity and hormone levels after unilateral cryptorchidism: association with pretreatment testicular location. J Urol 164:1697–1701PubMedCrossRef

28.

Marchetti F, Bua J, Tornese G, Piras G, Toffol G, Ronfani L, Italian Study Group on Undescended Testes ISGUT (2012) Management of cryptorchidism: a survey of clinical practice in Italy. BMC Pediatr 12(1):4PubMedCrossRef

29.

Mathers MJ, Sperling H, Rübben H, Roth S (2009) Hodenhochstand: diagnostik, therapie und langfristige konsequenzen. Dtsch Arztebl Int 106:527–532PubMed

30.

Miller KD, Coughlin MT, Lee PA (2001) Fertility after unilateral cryptorchidism. Paternity, time to conception, pretreatment testicular location and size, hormone and sperm parameters. Horm Res 55:249–253PubMedCrossRef

31.

Niederberger C, Joyce GF, Wise M, Meacham RB (2007) Male infertility. In: MS Litwin, CS Saigal (eds) Urologic diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. US Government Printing Office, Washington, DC, NIH Publication No. 07-5512, 2007, pp 461-481

32.

Paasch U, Thieme C, Grunewald S, Glander HJ (2004) Electronic data base systems support the evaluation of male infertility factors, example cryptorchidism. Urol Int 72:154–161PubMedCrossRef

33.

Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O (2007) Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 356:1835–1841PubMedCrossRef

34.

Pyörälä S, Huttunen NP, Uhari M (1995) A review and meta-analysis of hormonal treatment of cryptorchidism. J Clin Endocrinol Metab 80:2795–2799PubMedCrossRef

35.

Raivio T, Toppar J, Kaleva M, Virtanen H, Haavisto AM, Dunke L, Jänne OA (2003) Serum androgen bioactivity in cryptorchid and noncryptorchid boys during the postnatal reproductive hormone surge. J Clin Endocrinol Metab 88:2597–2599PubMedCrossRef

36.

Retief PJ (1977) Fertility in undescended testes. S Afr Med J 52:610–613PubMed

37.

Ritzén EM, Bergh A, Bjerknes R, Christiansen P, Cortes D, Haugen SE, Jörgensen N, Kollin C, Lindah lS, Lackgren G, Main KM, Nordenskjöld A, Rajpert-De Meyts E, Söder O, Taskinen S, Thorsson A, Thorup J, Toppari J, Virtanen H (2007) Nordic consensus on treatment of undescended testes. Acta Paediatr 96:638–643PubMedCrossRef

38.

Schwentner C, Oswald J, Kreczy A, Lunacek A, Bartsch B, Deibl M, Radmayr C (2005) Neoadjuvant gonadotropin-releasing hormone therapy before surgery may improve the fertility index in undescended testes: a prospective randomized trial. J Urol 173:974–977PubMedCrossRef

39.

Suomi AM, Main KM, Kaleva M, Schmidt IM, Chellakooty M, Virtanen HE, Boisen KA, Damgaard IN, Kai CM, Skakkebaek NE, Toppari J (2006) Hormonal changes in 3-month-old cryptorchid boys. J Clin Endocrinol Metab 91:953–958PubMedCrossRef

40.

Thorsson AV, Christiansen P, Ritzén M (2007) Efficacy and safety of hormonal treatment of cryptorchidism: current state of the art. Acta Paediatr 96:628–630PubMedCrossRef

41.

Virtanen HE, Toppari J (2008) Epidemiology and pathogenesis of cryptorchidism. Hum Reprod Updat 14:49–58CrossRef

Titel: The controversy regarding the need for hormonal treatment in boys with unilateral cryptorchidism goes on: a review of the literature
verfasst von: Barbara Ludwikowski
Ricardo González
Publikationsdatum: 01.01.2013
Verlag: Springer-Verlag
Erschienen in: European Journal of Pediatrics / Ausgabe 1/2013
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-012-1711-y

Neu im Fachgebiet Pädiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

16.05.2024 Arterielle Hypertonie in der Pädiatrie Nachrichten

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

Management of unstable pediatric hemato-oncology patient: results of a web-based survey to pediatric oncologists in Spain

Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene

Grisel syndrome as a complication of Kawasaki disease: a case report and review of the literature

A disease severity scoring system for children with type 1 Gaucher disease